These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32558439)

  • 1. Vascular Reactivity of Adult-Onset Systemic Lupus Erythematosus Patients.
    Adawi M; Abu-Gabel T; Sabbah F; Yehuda I; Tamir S; Blum A
    Isr Med Assoc J; 2020 Jun; 22(6):348-351. PubMed ID: 32558439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus.
    Svenungsson E; Cederholm A; Jensen-Urstad K; Fei GZ; de Faire U; Frostegård J
    Scand J Rheumatol; 2008; 37(5):352-9. PubMed ID: 18666029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-dependent but not endothelium-independent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: a metaanalysis and metaregression.
    Mak A; Liu Y; Ho RC
    J Rheumatol; 2011 Jul; 38(7):1296-303. PubMed ID: 21459950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients.
    Karadag O; Calguneri M; Atalar E; Yavuz B; Akdogan A; Kalyoncu U; Bilgen SA; Ozer N; Ertenli AI; Ovunc K; Kiraz S
    Clin Rheumatol; 2007 May; 26(5):695-9. PubMed ID: 16909327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lumbar spine bone mineral density predicts endothelial reactivity in patients with systemic lupus erythematosus.
    Mak A; Ling LH; Ho RC; Gong L; Cheak AA; Yee H; Vasoo S; Koh DR; Robless PA
    Clin Exp Rheumatol; 2011; 29(2):261-8. PubMed ID: 21385541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction in systemic lupus erythematosus - a case-control study and an updated meta-analysis and meta-regression.
    Mak A; Kow NY; Schwarz H; Gong L; Tay SH; Ling LH
    Sci Rep; 2017 Aug; 7(1):7320. PubMed ID: 28779080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Dysfunction in Systemic Lupus Erythematosus: Pathogenesis, Assessment and Therapeutic Opportunities.
    Mauro D; Nerviani A
    Rev Recent Clin Trials; 2018; 13(3):192-198. PubMed ID: 29542419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brachial endothelial function is impaired in patients with systemic lupus erythematosus.
    Lima DS; Sato EI; Lima VC; Miranda F; Hatta FH
    J Rheumatol; 2002 Feb; 29(2):292-7. PubMed ID: 11842823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Disease Duration on Vascular Surrogates of Early Atherosclerosis in Childhood-Onset Systemic Lupus Erythematosus.
    Barsalou J; Bradley TJ; Tyrrell PN; Slorach C; Ng LW; Levy DM; Silverman ED
    Arthritis Rheumatol; 2016 Jan; 68(1):237-46. PubMed ID: 26361097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women.
    El-Magadmi M; Bodill H; Ahmad Y; Durrington PN; Mackness M; Walker M; Bernstein RM; Bruce IN
    Circulation; 2004 Jul; 110(4):399-404. PubMed ID: 15262847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction and arterial stiffness in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
    Mendoza-Pinto C; Rojas-Villarraga A; Molano-González N; García-Carrasco M; Munguía-Realpozo P; Etchegaray-Morales I; Morales-Sánchez H; Berra-Romani R; Cervera R
    Atherosclerosis; 2020 Mar; 297():55-63. PubMed ID: 32078830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between serum total antioxidant status and flow-mediated dilation in patients with systemic lupus erythematosus: an observational study.
    Sincer İ; Kurtoğlu E; Yılmaz Çoşkun F; Aktürk S; Vuruşkan E; Düzen İV; Saraçoğlu E; Aktürk E; Hidayet Ş
    Anatol J Cardiol; 2015 Nov; 15(11):913-8. PubMed ID: 25868041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus.
    Somers EC; Marder W; Kaplan MJ; Brook RD; McCune WJ
    Ann N Y Acad Sci; 2005 Jun; 1051():271-80. PubMed ID: 16126968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial wall dysfunction in systemic lupus erythematosus.
    Cypiene A; Kovaite M; Venalis A; Dadoniene J; Rugiene R; Petrulioniene Z; Ryliskyte L; Laucevicius A
    Lupus; 2009 May; 18(6):522-9. PubMed ID: 19395454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.
    Sharma SK; Rathi M; Sahoo S; Prakash M; Dhir V; Singh S
    Lupus; 2016 Apr; 25(5):525-31. PubMed ID: 26678442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.
    Kiss E; Soltesz P; Der H; Kocsis Z; Tarr T; Bhattoa H; Shoenfeld Y; Szegedi G
    J Autoimmun; 2006 Dec; 27(4):211-7. PubMed ID: 17088047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
    PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors.
    Cavazzana I; Piantoni S; Sciatti E; Fredi M; Taraborelli M; Bonadei I; Airò P; Metra M; Tincani A; Franceschini F; Vizzardi E
    Lupus; 2019 Feb; 28(2):210-216. PubMed ID: 30608206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of subclinical cardiovascular abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index.
    Palmieri V; Migliaresi P; Orefice M; Lupo T; Di Minno MN; Valentini G; Celentano A
    Nutr Metab Cardiovasc Dis; 2009 May; 19(4):234-40. PubMed ID: 19157818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macro- and microvascular function in habitually exercising systemic lupus erythematosus patients.
    Barnes JN; Nualnim N; Dhindsa M; Renzi CP; Tanaka H
    Scand J Rheumatol; 2014; 43(3):209-16. PubMed ID: 24392783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.